Atomo Diagnostics Limited
Climate Impact & Sustainability Data (2020, 2022, 2023-06-30, 2024)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Economic, Environmental and Social Sustainability Risks
Climate Goals & Targets
Environmental Challenges
- Material exposure to economic, environmental and social sustainability risks
Mitigation Strategies
- The Company should disclose how it manages or intends to manage those risks.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Employee health and safety
- Product quality and safety
- Ethical purchasing and human rights in the supply chain
- Corruption and bribery
- Compliance
- Resource use and waste management
- Product pricing and accessibility
Environmental Achievements
- Recycled pallet production targets reduction in wood use, changes to packaging reduce plastic use and with production based in South Africa our operations base is closer to primary LMIC markets helping to minimise logistics and supply chain impacts
Social Achievements
- Simply Better Rewards program to acknowledge staff that demonstrate core values
- Focus on better virtual collaboration as global footprint grows
- Steptember global step challenge encouraging wellness
Governance Achievements
- Strict compliance with corporate governance standards
- Board prioritises people, strategies and practices that instil and reinforce the company’s purpose and values, ensure health and wellbeing, and meet diversity and inclusion objectives
Climate Goals & Targets
Environmental Challenges
- Customers and target customers in the diagnostics industry continued to focus their efforts and investment on responding to demand for COVID-19 testing solutions and prioritised these over other opportunities. This continued to delay some opportunities for Atomo to move more quickly ahead with new partnerships for OEM sales or finished product development.
Mitigation Strategies
- Continuing to support customer demand for COVID-19 testing solutions as and when required, and in the event that new variants impact on the dynamics of the market; Continue to expand the Atomo HIV Self-Test and point of care business, including growing the Australian market, working with existing distributors to ramp up activity in the UK, Europe and global health markets, and targeting the appointment of new distributors for the Atomo HIV professional use product; Build and expand the OEM customer pipeline with continued ramp up in market-facing activities in developed markets, in particular Australia, North America and UK/Europe; Finalise development and optimisation of the Atomo swab device and seek initial commercialisation partners; and Continue to work on integration of digital functionality to enhance Atomo’s product offerings, in particular the Atomo App for home use and a clip in reader for point of care settings.
Supply Chain Management
Responsible Procurement
- Responsibility to partners to ensure our product line is free from human rights concerns such as forced labour and trafficking, unsafe labour standards and unfair treatment.
Climate-Related Risks & Opportunities
Reporting Period: 2023-06-30
Environmental Metrics
ESG Focus Areas
- Product Quality & Safety
- Ethical Purchasing & Human Rights in the Supply Chain
- Corruption & Bribery
- Environmental Regulation
- Resource Use & Waste Management
- Product Pricing & Accessibility
- Safe & Healthy Employment Compliance
Social Achievements
- Introduced a Learning and Development platform offering a wide range of courses and resources designed to empower our people with skills and knowledge they need to support their personal and professional development.
- Came together for a workshop to raise awareness and equip our staff with tools to support their peers and recognise early signs of mental health and promoted open and honest conversations through active participation in R U OK day.
Governance Achievements
- Established a Nomination and Remuneration Committee (later renamed People, Culture, Nomination and Remuneration Committee) to monitor and make recommendations to the Board in relation to recruitment, retention, termination policies, people strategies, diversity objectives, and performance appraisal processes.
Climate Goals & Targets
Long-term Goals:
- Continued growth in HIV Self-Test sales with increased participation in global health tenders, targeted entry into private sector markets in Asia and the Americas, and growth in higher margin developed markets including Australia, the UK and Europe through retail focused distribution and government engagement.
- Focus on the expansion of Atomo's Point of Care technology supply business, especially in the US market where the recent FDA 510(k) clearance obtained by Lumos Diagnostics for their test on the Atomo Pascal device opens a pathway for Atomo and its partners.
Medium-term Goals:
- Secure new Point-of-Care Technology customers through Atomo’s expanding reseller network supported by continued success of existing finished products in winning consumer health channel contracts and key market regulatory approvals.
- Support NG Biotech and Lumos as they continue to scale the commercial rollout of their Pascal based tests in global markets.
Short-term Goals:
- Launch the pregnancy test in Australia and New Zealand and commence clinical trials in the US with a view to securing a US commercial partner in advance of product approval to de-risk ‘go to market’ for Atomo shareholders.
- Complete product validation activities related to Atomo’s iron deficiency (ferritin) test and submit the product dossier for regulatory approval in Australia, Europe & the UK.
Environmental Challenges
- Regulatory risk: Obtaining and maintaining product approvals in multiple jurisdictions.
- Product quality and safety: Potential for negative financial and/or reputational impacts should quality or safety issues arise.
- Compliance: Driving compliance with legal and regulatory requirements applicable to our global business.
- Supply chain: Potential exposure to supply chain disruption risks.
- Employees and skilled labour: Reliance on key qualified personnel.
- Operational risk: Potential exposure to additional political, legal, economic and regulatory risk specific to international operations (South Africa).
- Competitive industry: Need to provide diagnostics at competitive prices.
- Corruption and bribery: Ensuring ethical business practices.
- Resource use and waste management: Managing energy usage, water usage, and medical waste.
- Climate risk: Potential future implementation of a formal review and policy response.
Mitigation Strategies
- Sourcing materials from quality suppliers, complying with ISO 13485 Medical Devices Quality Management, and delivering safe products to customers; investigating all concerns to ensure products maintain the highest quality.
- Developing policies and controls, communication and training, oversight and continuous improvement.
- Staying closely engaged with its supply chain and ensuring sufficient stock on hand.
- Ensuring employees are appropriately remunerated and work in a safe environment; addressing health and safety concerns and mitigating the risk of reoccurrence of incidents.
- Strategies and initiatives designed to provide diagnostics at competitive prices.
- Conducting business with transparency and free from unethical persuasion.
- Considering energy usage, water usage, and waste as a by-product of manufacture, with particular consideration given to the fact that the products are classified as medical waste upon use.
Supply Chain Management
Responsible Procurement
- Responsibility to partners to ensure our product line is free from human rights concerns such as forced labour and trafficking, unsafe labour standards and unfair treatment
Climate-Related Risks & Opportunities
Reporting Period: 2024
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Employee health and safety
- Product quality and safety
- Ethical purchasing and human rights in the supply chain
- Corruption and bribery
- Compliance
- Resource use and waste management
- Product pricing and accessibility
Social Achievements
- Maintained at least 40% gender diversity within the workforce.
- Completed a pay equity review with industry standards met.
Governance Achievements
- Enhanced its governance framework to align with the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations (4th Edition).
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Not disclosed
Mitigation Strategies
- Not disclosed
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Ethical purchasing and human rights in the supply chain
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations (4th Edition)
Certifications: ISO 13485
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed